Medical costs

Have you jumped on the weight-loss medication bandwagon yet? Have you wondered whether there’s finally a way for you to shed those extra pounds that have been plaguing you for decades and return to your svelte days of yesteryear? Although we’ve previously told you that a bit of extra weight…

If you or a loved one suffers from mild cognitive impairment or have been diagnosed with early Alzheimer’s Disease, you’ve likely followed the news over the last few months about a new treatment awaiting FDA approval. Well, that FDA approval has arrived: Leqembi, a medication that targets the amyloid plaques…

For the more than 6 million Americans currently thought to have Alzheimer’s, and their loved ones, the possible benefits of new medications can’t come soon enough. As the most common cause of dementia, Alzheimer’s Disease predominantly afflicts older women (⅔ of Alzheimer’s patients are female) and almost ¾ of those…

As a follow-up to our previous article portending the next new drug for Alzheimer’s, the FDA has now given approval under its accelerated approval pathway to the new medication Leqembi (originally known as Lecanemab). This drug was developed to help slow down cognitive decline in those with Mild Cognitive Impairment…

You may remember that more than a year ago, we posted a story on the arrival of a new drug approved by the FDA for the treatment of Alzheimer’s disease. That drug is Aduhelm, and while it is technically on the market and available, its use has been greatly limited…

With the passage of the Medicare Modernization Act of 2003, the Medicare Part D Subscription Drug Program became law, and Medicare beneficiaries finally received help paying for outpatient prescription drugs they obtain at their local pharmacy. However, this law prohibited Medicare from negotiating drug prices for its beneficiaries. Thus, pharmaceutical…